BETH DEGEYTER: Open Payments
NPI 1366157737 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,052 in 49 payments from 16 companies in 2025. Trend: 2023 $241 · 2024 $1,409 · 2025 $1,052
Food & beverage: $1,052
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $241 |
| ABBVIE INC. | 11 | $172 |
| AstraZeneca Pharmaceuticals LP | 6 | $96 |
| PFIZER INC. | 4 | $89 |
| Exact Sciences Corporation | 3 | $64 |
| Astellas Pharma US Inc | 3 | $62 |
| Lilly USA, LLC | 3 | $57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| Novo Nordisk Inc | 2 | $41 |
| Kowa Pharmaceuticals America, Inc. | 2 | $36 |
Products named: Auvelity, AIRSUPRA, UBRELVY, Cologuard Collection Kit, PREVNAR 20, Veozah, XIFAXAN, Wegovy.
Industry payments across LA — which companies pay providers there.
